HUMAN EMBRYONIC STEM CELLS
CONTENTS PART I: POLICY 1 ETHICAL ISSUES ASSOCIATED WITH PLURIPOTENT STEM CELLS 2 A RESEARCHER’S GUIDE TO FEDERALLY FUNDED HUMAN EMBRYONIC STEM CELL RESEARCH IN THE UNITED STATES 3 INTELLECTUAL PROPERTY OF HUMAN PLURIPOTENT STEM CELLS PART II: TYPES OF PLURIPOTENT CELLS 4 EMBRYONAL CARCINOMA CELLS: THE MALIGNANT COUNTERPARTS OF ES AND EG CELLS 5 HUMAN PLURIPOTENT STEM CELLS FROM BONE MARROW 6 PROTOCOLS FOR THE ISOLATION AND MAINTENANCE OF HUMAN EMBRYONIC STEM CELLS 7 SUBCLONING AND ALTERNATIVE METHODS FOR THE DERIVATION AND CULTURE OF HUMAN EMBRYONIC STEM CELLS PART III: DIFFERENTIATION 8 DIFFERENTIATION OF NEUROEPITHELIA FROM HUMAN EMBRYONIC STEM CELLS 9 PANCREATIC DIFFERENTIATION OF PLURIPOTENT STEM CELLS 10 HUMAN EMBRYONIC STEM CELL-DERIVED CARDIOMYOCYTES: DERIVATION AND CHARACTERIZATION 11 VASCULAR LINEAGE DIFFERENTIATION FROM HUMAN EMBRYONIC STEM CELLS 12 HEMATOPOIETIC PROGENITORS DERIVED FROM HUMAN EMBRYONIC STEM CELLS PART IV: THERAPEUTICS 13 HUMAN EMBRYONIC VS ADULT STEM CELLS FOR TRANSPLANTATION THERAPIES 14 GENETIC MANIPULATION OF HUMAN EMBRYONIC STEM CELLS 15 HUMAN THERAPEUTIC CLONING 16 THERAPEUTIC USES OF EMBRYONIC STEM CELLS 17 HUMAN EMBRYONIC STEM CELLS AND THE FOOD AND DRUG ADMINISTRATION: ASSURING THE SAFETY OF NOVEL CELLULAR THERAPIES 18 STUDIES OF A HUMAN NEURON-LIKE CELL LINE IN STROKE AND SPINAL CORD INJURY: PRECLINICAL AND CLINICAL PERSPECTIVES ETHICAL ISSUES